This trial will test whether mirtazapine is an effective and safe treatment for chronic insomnia in older adults.
2 Primary · 0 Secondary · Reporting Duration: For Mirtazapine and placebo group : Assess the change in the Insomnia Severity Index between the initial examination (Day 1) and the end of the treatment course (Day 36)
60 Total Participants · 2 Treatment Groups
Primary Treatment: Mirtazapine 7.5 MG Oral Tablet once daily at bedtime · Has Placebo Group · Phase 1
Age 65+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: